Trade Bristol Myers ^BMY

Bank Julius Baer & Co. Ltd Zurich Purchases 73,200 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb (NYSE:BMY) Stock Gets Price Target Trim from Morgan Stanley - Zolmax

Learn Why The Bull Case For Bristol Myers Squibb Stock Could Change Following Earnings Beat

Molecular and immune heterogeneity across limited-stage and extensive-stage small cell lung cancer

Mirae Asset Global Investments Co. Ltd. Makes New Investment in Bristol Myers Squibb Company $BMY

Sumitomo Mitsui Trust Group Inc. Sells 19,128 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Hengrui's third-quarter profit rebounds on out-licensing revenue

Why Everyone Is Watching Bristol-Myers Squibb (BMY) Today

What Bristol Myers Squibb Stock's Earnings Beat Means For Shareholders

Bristol Myers Squibb Company $BMY Stock Bought by Americana Partners LLC - Markets Daily

Bristol Myers Squibb Company $BMY Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

Birinyi Associates Inc. Purchases New Position in Bristol Myers Squibb Company $BMY

Americana Partners LLC Acquires 46,008 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company $BMY Stock Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Stock Price Target Cut by Morgan Stanley - Stock Observer

Is Bristol-Myers Squibb (BMY) Stock Cheap, Or Are Risks Priced In?

Bristol Myers Squibb Q3 Earnings Call Highlights

Head and Neck Squamous Cell Carcinoma Market Size in the 7MM is projected to reach nearly USD 2,560 million by 2036, growing at a CAGR of 10.5% during 2026-2036 | DelveInsight | ABNewswire

Neuroendocrine Prostate Cancer Market and Pipeline Appear Robust With Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | ABNewswire

Bristol Myers Squibb (NYSE:BMY) Posts Earnings Results, Beats Expectations By $0.25 EPS

AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock (VEEV)

Drugmakers Shrug Off Trump Pricing Pressure With Record Revenue

BMY Q3 Earnings Tops Estimates, Higher Charges Weigh on Outlook

Bristol-Myers Squibb Slashes FY26 EPS Outlook, But Raises Revenue Forecast - Update

Bristol Myers Squibb Raises Fiscal Year Outlook as 3Q Revenue Rises | Morningstar

Bristol Myers Squibb Co. Q3 Income Retreats

Bristol-Myers Squibb Beat Estimates but Cut EPS Guidance in Q3 2026

Clinical risk factors alone do not predict the development of moderate-severe chronic graft-versus-host disease after hematopoietic cell transplantation and post-transplant cyclophosphamide

Enhanced cfDNA methylation profiling by detection and correction of jagged ends

Anthropic acquires one-person biotech startup that used Claude to develop promising muscular dystrophy treatment in 18 months

Anthropic buys a one-person biotech and starts its own drug programmes

Bristol Myers Squibb Company $BMY Stock: Roman Butler Fullerton & Co. Trims Holdings

Cardiff Names Alland Interim Medical Chief Ahead Of Planned Phase 3 Cancer Trial

FY2026 Earnings Estimate for BMY Issued By Erste Group Bank - Stock Observer

KKR Invests $475 Million in Alexandria Real Estate Equities' Campus Point | Valuespectrum.com

Bristol Myers Squibb (BMY) Stock Fair Value Edges Lower On Split Analyst Views

Bristol Myers Squibb (BMY) Stock Still Looks Reasonable Below Fair Value

Bristol Myers Squibb Company $BMY Stock Purchased by Simplicity Wealth LLC - Markets Daily

Leo Wealth LLC Purchases 39,189 Shares of Bristol Myers Squibb Company $BMY

Vamsi Tekuru Appointed Managing Director of Bristol Myers Squibb India, ETGCC

Bristol Myers Squibb Company $BMY Stock: Arnhold LLC Decreases Position

BMY Stock Rises on Trial Data, With Implications for EXEL

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?

RiskVantage AI Unveils Explainable, Sovereign AI for the $75 Billion Contract and Deal Legal Market at Dubai AI Festival

3 Blue-Chip Dividend Stocks That Show Why Roth IRA Income Can Be Worth More

Bristol Myers (BMY) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Bristol Myers Squibb (NYSE:BMY) Given New $78.00 Price Target at Piper Sandler

ChatGPT Enterprise vs Microsoft 365 Copilot 2026: Pricing, Customer Results and Top 10 Enterprise AI Platforms

BioNTech, Bristol Myers' Pumitamig Shows 36.7% Response Rate In Phase 2 NSCLC Trial

Citizens Financial Group Inc. RI Buys 44,768 Shares of Bristol Myers Squibb Company $BMY

Tempus AI's (TEM) Buy Rating Reiterated at Needham & Company LLC - Zolmax

Bristol Myers Squibb Company $BMY Stake Lessened by Lantern Wealth Advisors LLC - Zolmax

Bristol Myers Squibb Company $BMY Stock Position Decreased by Lantern Wealth Advisors LLC - Markets Daily

Bristol Myers Squibb Company $BMY Shares Acquired by Brookstone Capital Management

The Call Bristol-Myers Squibb Bulls Got Right

Bristol Myers Squibb Reports Patient Death in MS CAR-T Therapy Trial, ETPharma

31,873 Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc.

Bristol Myers Squibb (NYSE:BMY) Cut to "Hold" at Zacks Research

Bristol Myers Squibb (NYSE:BMY) Downgraded by Zacks Research to Hold - Stock Observer

Tempus AI, Inc. $TEM Shares Bought by Washington Trust Advisors Inc. - Stock Observer

Bristol Myers Squibb (NYSE:BMY) & Astellas Pharma (OTCMKTS:ALPMY) Financial Analysis - Daily Political

Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial

Tempus AI (NASDAQ:TEM) Stock Rating Reaffirmed as Buy by Needham & Company LLC - Markets Daily

Tempus AI's (TEM) "Buy" Rating Reiterated at Needham & Company LLC - Markets Daily

Bristol Myers Squibb Moves On Two Fronts: MS Cell Therapy Data And Tempus AI Expansion; Stock Down

Bristol Myers Squibb Reports CAR T-Cell Therapy Data In Multiple Sclerosis

Fifth edition of MCADDI 2026 to be held at University of Hyderabad from October 25

Tempus AI Expands Bristol Myers Partnership With Multi-Year Oncology, AI Data Deals | Morningstar

Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026 | Morningstar

Tempus AI (NASDAQ:TEM) Stock Rating Reaffirmed as "Buy" by Needham & Company LLC - Stock Observer

Tempus AI (NASDAQ:TEM) Earns Buy Rating from Needham & Company LLC - Stock Observer

Tempus AI (NASDAQ:TEM) Given "Buy" Rating at Needham & Company LLC - Stock Observer

Tempus AI's (TEM) "Buy" Rating Reaffirmed at Needham & Company LLC - Stock Observer

Tempus AI's (TEM) Buy Rating Reiterated at Needham & Company LLC - Stock Observer

Tempus AI (NASDAQ:TEM) Stock Keeps Buy Rating at Needham & Company LLC - Stock Observer

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Pathos AI Announces Strategic Collaborations with Bristol Myers Squibb and Tempus AI to Advance AI-Driven Drug Development Beginning with Alzheimer's Disease and Other Neurological Conditions | Morningstar

3 Defensive Stocks to Buy as the AI Selloff Rattles Wall Street

NBT Bank N.A. Buys 52,930 Shares of Bristol Myers Squibb Company $BMY

What is Erste Group Bank's Estimate for BMY FY2027 Earnings? - Stock Observer

Bispecific dual T cell agonist invikafusp alfa in solid tumors: the phase 1/2 START-001 trial

Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial

Why Bristol-Myers Squibb (BMY) Is Back In The Spotlight

BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead's TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer | Morningstar

Amgen Inc. $AMGN Shares Sold by Foster Victor Wealth Advisors LLC

Astellas Pharma (OTCMKTS:ALPMY) versus Bristol Myers Squibb (NYSE:BMY) Financial Analysis - Zolmax

Bristol Myers Squibb (BMY) Expected to Release Earnings on Thursday

Ovarian Cancer Pipeline 2026: Emerging Drugs, Regulatory Milestones, and Strategic Moves by Leading Players | Pfizer, Daiichi Sankyo, Astellas Pharma, Jiangsu HengRui, Boehringer Ingelheim, Impact | ABNewswire

Bristol Myers Squibb Company $BMY Shares Sold by SteelPeak Wealth LLC

RBC Capital Reaffirms Their Hold Rating on Sanofi (SNYNF)

RBC Capital Remains a Buy on Eli Lilly & Co (LLY)

Bristol Myers Squibb Company $BMY Stock Sold by Robeco Institutional Asset Management B.V. - Daily Political

Sumitomo Mitsui DS Asset Management Company Ltd Sells 21,624 Shares of Bristol Myers Squibb Company $BMY - Daily Political

NATCO launches Chemo drug in US

Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?

Gold Price Forecast UAE 2026–2030: What Could 24K Gold Cost per Gram?

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

US Dollar Index Holds Near 102 Ahead of US Midterm Elections

Gold Price Today: Gold Reclaims $3,900 as Fed Rate Concerns Weigh on Recovery

Palantir Q3 Earnings Preview: Can AI Growth Support PLTR’s Valuation?

AMD Earnings Preview: Can AI Chip Growth Reverse the Stock’s 11% Sell-Off?

Gold Price Forecast This Week: Can XAU/USD Recover After Crashing Below $3,900?

Intel Stock Plunges About 30% as Alphabet Sell-Off Deepens AI Spending Concerns

US Midterm Elections 2026: What the Results Could Mean for Stocks, Gold and the US Dollar

Oil Price Today: Brent Falls Below $112 as Iran Talks Ease Supply Fears